Mitchell C. Posner to Immunity, Cellular
This is a "connection" page, showing publications Mitchell C. Posner has written about Immunity, Cellular.
Connection Strength
0.071
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903. Ann Surg Oncol. 2008 Jan; 15(1):158-64.
Score: 0.071